Corticosteroid insensitivity in severe asthma: Significance, mechanisms and aetiology

Internal Medicine Journal

Volumn 40, Issue 5, 2010, Pages 323-334

  Hew, M ^a   Chung, K F ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Aetiology; Asthma; Drug effect; Drug therapy; Steroid

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 10; MEPOLIZUMAB; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OMALIZUMAB; VITAMIN D;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHROMATIN; CIGARETTE SMOKING; DISEASE CONTROL; DISEASE SEVERITY; DRUG MECHANISM; ENVIRONMENTAL FACTOR; EVALUATION; HEREDITY; HUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ADRENAL CORTEX HORMONES; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG RESISTANCE; HUMANS; OBESITY; SMOKING;

EID: 77952732147     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2010.02192.x     Document Type: Review

References (85)

1. Chung KF, Godard P, Adelroth E, Ayres J, Barnes N, Barnes P et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999 13: 1198-1208.
2. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L et al. National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007 119: 405-413.
3. Harrison BD. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005 35: 543-547.
4. Stirling RG, Chung KF. Severe asthma: definition and mechanisms. Allergy 2001 56: 825-840.
5. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF Asthma and Allergy Research Group of the National Heart and Lung Institute. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003 22: 478-483.
6. British Thoracic Society, Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. 2008. [cited 2009 Apr 16] Available from URL: http://www.sign.ac.uk/pdf/sign101.pdf
7. American Thoracic Society (ATS). Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000 162: 2341-2351.
8. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 31: 143-178.
9. Miller MK, Johnson C, Miller DP, Deniz Y, Bleecker ER, Wenzel SE TENOR Study Group. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 2005 116: 990-995.
10. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008 32: 545-554.
11. ENFUMOSA. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003 22: 470-477.
12. Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF et al. National Heart, Lung, and Blood Institute Severe Asthma Research Program. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol 2008 104: 394-403.
13. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999 160: 1532-1539.
14. Pepe C, Foley S, Shannon J, Lemiere C, Olivenstein R, Ernst P et al. Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 2005 116: 544-549.
15. Bourdin A, Neveu D, Vachier I, Paganin F, Godard P, Chanez P. Specificity of basement membrane thickening in severe asthma. J Allergy Clin Immunol 2007 119: 1367-1374.
16. Planagumà A, Kazani S, Marigowda G, Haworth O, Mariani TJ, Israel E et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 2008 178: 574-582.
17. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008 372: 1107-1119.
18. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998 53: 315-321.
19. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009 360: 973-984.
20. Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L et al. International Mepolizumab Study Group. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 2007 176: 1062-1071.
21. Simpson JL, Powell H, Boyle MJ, Scott RJ, Gibson PG. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med 2008 177: 148-155.
22. Brasier AR, Victor S, Boetticher G, Ju H, Lee C, Bleecker ER et al. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008 121: 30-7.
23. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008 178: 218-224.
24. Woolcock AJ. Corticosteroid-resistant asthma: definitions. Am J Respir Crit Care Med 1996 154: S45 S48.
25. Chan MT, Leung DY, Szefler SJ, Spahn JD. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma. J Allergy Clin Immunol 1998 101: 594-601.
26. Colice GL, Stampone P, Leung DY, Szefler SJ. Oral corticosteroids in poorly controlled asthma. J Allergy Clin Immunol 2005 115: 200-201.
27. Demoly P, Jaffuel D, Mathieu M, Sahla H, Godard P, Michel FB et al. Glucocorticoid insensitive asthma: a one year clinical follow up pilot study. Thorax 1998 53: 1063-1065.
28. Carmichael J, Paterson IC, Diaz P, Crompton GK, Kay AB, Grant IW. Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) 1981 282: 1419-1422. (Pubitemid 11096240) (Pubitemid 11096240)
29. Poznansky MC, Gordon AC, Douglas JG, Krajewski AS, Wyllie AH, Grant IW. Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci (Lond) 1984 67: 639-645.
30. Corrigan CJ, Brown PH, Barnes NC, Szefler SJ, Tsai JJ, Frew AJ et al. Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991 144: 1016-1025.
31. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. 'Refractory' eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004 170: 601-605.
32. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006 174: 134-141.
33. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 2008 63: 784-790.
34. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990 336: 137-140.
35. Milgrom H, Fick RB Jr., Su JQ, Reimann JD, Bush RK, Watrous ML et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999 341: 1966-1973.
36. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009 360: 985-993.
37. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 2006 354: 697-708.
38. Miner JN, Ardecky B, Benbatoul K, Griffiths K, Larson CJ, Mais DE et al. Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile. Proc Natl Acad Sci USA 2007 104: 19244-19249.
39. Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2006 117: 522-543.
40. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994 93: 33-9.
41. Matthews JG, Ito K, Barnes PJ, Adcock IM. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 2004 113: 1100-1108.
42. Adcock IM, Lane SJ, Brown CR, Peters MJ, Lee TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995 154: 3500-3505.
43. Goleva E, Li LB, Eves PT, Strand MJ, Martin RJ, Leung DY. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid- insensitive asthma. Am J Respir Crit Care Med 2006 173: 607-616.
44. Goecke IA, Alvarez C, Henríquez J, Salas K, Molina ML, Ferreira A et al. Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Mol Immunol 2007 44: 2115-2123.
45. Vrugt B, Wilson S, Bron A, Shute J, Holgate ST, Djukanovic R et al. Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T-cell proliferation. Eur Respir J 2000 15: 478-485.
46. John M, Lim S, Seybold J, Jose P, Robichaud A, O'Connor B et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998 157: 256-262.
47. Hawrylowicz C, Richards D, Loke TK, Corrigan C, Lee T. A defect in corticosteroid-induced IL-10 production in T lymphocytes from corticosteroid-resistant asthmatic patients. J Allergy Clin Immunol 2002 109: 369-370.
48. Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006 116: 146-155.
49. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol 2006 533: 118-132.
50. Hew M. Corticosteroid insensitivity in severe asthma PhD thesis]. London: National Heart & Lung Institute, Imperial College London, May 2007.
51. Thalhamer T, McGrath MA, Harnett MM. MAPKs and their relevance to arthritis and inflammation. Rheumatology (Oxford) 2008 47: 409-414.
52. Sweeney SE, Firestein GS. Mitogen activated protein kinase inhibitors: where are we now and where are we going? Ann Rheum Dis 2006 65 (Suppl 3 iii83-8.
53. Lane SJ, Adcock IM, Richards D, Hawrylowicz C, Barnes PJ, Lee TH. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes. J Clin Invest 1998 102: 2156-2164.
54. Loke TK, Mallett KH, Ratoff J, O'Connor BJ, Ying S, Meng Q et al. Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid- resistant asthmatic patients. J Allergy Clin Immunol 2006 118: 368-375.
55. Desmet C, Gosset P, Henry E, Garzé V, Faisca P, Vos N et al. Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1. Am J Respir Crit Care Med 2005 172: 671-678.
56. Cosio BG, Iglesias A, Rios A, Noguera A, Sala E, Ito K et al. Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease. Thorax 2009 64: 424-429.
57. Gross KL, Lu NZ, Cidlowski JA. Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol 2009 300: 7-16.
58. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009 373: 1905-1917.
59. Hearing SD, Norman M, Smyth C, Foy C, Dayan CM. Wide variation in lymphocyte steroid sensitivity among healthy human volunteers. J Clin Endocrinol Metab 1999 84: 4149-4154.
60. Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E et al. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J Clin Invest 1991 87: 680-686.
61. Hakonarson H, Bjornsdottir US, Halapi E, Bradfield J, Zink F, Mouy M et al. Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc Natl Acad Sci USA 2005 102: 14789-14794.
62. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007 104: 15858-15863.
63. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004 13: 1353-1359.
64. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993 151: 3460-3466.
65. Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DY. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Crit Care Med 1997 155: 87-93.
66. Bellettato C, Adcock IM, Ito K, Caramori G, Casolari P, Ciaccia A et al. Rhinovirus infection reduces glucocorticoid receptor nuclear translocation in airway epithelial cells. Eur Respir J 2003 22 (Suppl 565S.
67. Li LB, Goleva E, Hall CF, Ou LS, Leung DY. Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway. J Allergy Clin Immunol 2004 114: 1059-1069.
68. Gilliland FD, Islam T, Berhane K, Gauderman WJ, McConnell R, Avol E et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med 2006 174: 1094-1100.
69. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000 15: 470-477.
70. Chalmers GW, MacLeod KJ, Thomson L, Little SA, McSharry C, Thomson NC. Smoking and airway inflammation in patients with mild asthma. Chest 2001 120: 1917-1922.
71. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003 168: 1308-1311.
72. Pedersen SE, Bateman ED, Bousquet J, Busse WW, Yoxall S, Clark TJ Gaining Optimal Asthma controL Steering Committee and Investigators. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma control study. J Allergy Clin Immunol 2007 120: 1036-1042.
73. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001 15: 1110-1112.
74. Livingston E, Darroch CE, Chaudhuri R, McPhee I, McMahon AD, Mackenzie SJ et al. Glucocorticoid receptor alpha:beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol 2004 114: 1475-1478.
75. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J Exp Med 2006 203: 7-13.
76. Chaudhuri R, Livingston E, McMahon AD, Lafferty J, Fraser I, Spears M et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006 174: 127-133.
77. Spears M, Donnelly I, Jolly L, Brannigan M, Ito K, McSharry C et al. Effect of theophylline plus beclometasone on lung function in smokers with asthma-a pilot study. Eur Respir J 2009 33: 1010-1017.
78. Lazarus SC, Chinchilli VM, Rollings NJ, Boushey HA, Cherniack R, Craig TJ et al. National Heart Lung and Blood Institute's Asthma Clinical Research Network. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007 175: 783-790.
79. Sin DD, Sutherland ER. Obesity and asthma. Thorax 2008 63: 1018-1023.
80. Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008 63: 14-20.
81. Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006 27: 495-503.
82. Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008 178: 682-687.
83. Eneli IU, Skybo T, Camargo CA Jr. Weight loss and asthma: a systematic review. Thorax 2008 63: 671-676.
84. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 2007 120: 1031-1035.
85. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009 179: 765-771.